Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.05% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 9.2% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Herc Holdings
HRI
$5.8B
| $21.3M | ﹤0.01% |
161,953
+33,686
| +26% | +$4.14M |
|
|
AQUA
1502
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $21.3M | ﹤0.01% |
537,667
-27,729
| -5% | -$1.09M |
|
1503
Skywest
SKYW
$4.18B
| $21.3M | ﹤0.01% |
1,288,628
-20,854
| -2% | -$365K |
|
1504
Designer Brands
DBI
$299M
| $21.3M | ﹤0.01% |
2,175,021
+472,235
| +28% | +$6.37M |
|
1505
Griffon
GFF
$4.72B
| $21.3M | ﹤0.01% |
594,089
-10,206
| -2% | -$341K |
|
1506
Archrock
AROC
$6.08B
| $21.2M | ﹤0.01% |
2,365,610
+895,086
| +61% | +$7.17M |
|
|
AGR
1507
DELISTED
Avangrid, Inc.
AGR
| $21.2M | ﹤0.01% |
493,505
+71,844
| +17% | +$2.98M |
|
1508
Vir Biotechnology
VIR
$1.56B
| $21.2M | ﹤0.01% |
836,400
+106,313
| +15% | +$2.61M |
|
1509
Element Solutions
ESI
$9.46B
| $21.1M | ﹤0.01% |
1,162,311
-15,739
| -1% | -$284K |
|
|
MDRX
1510
DELISTED
Veradigm Inc. Common Stock
MDRX
| $21.1M | ﹤0.01% |
1,197,685
-123,451
| -9% | -$2.07M |
|
1511
Wabash National
WNC
$512M
| $21.1M | ﹤0.01% |
933,578
-665,422
| -42% | -$14.4M |
|
1512
Vanguard High Dividend Yield ETF
VYM
$84B
| $21M | ﹤0.01% |
194,517
-8,688
| -4% | -$924K |
|
1513
Virtus Investment Partners
VRTS
$1.13B
| $21M | ﹤0.01% |
109,882
+21,474
| +24% | +$3.84M |
|
1514
Trip.com Group
TCOM
$28.3B
| $21M | ﹤0.01% |
611,303
+6,711
| +1% | +$193K |
|
1515
Axalta
AXTA
$7.99B
| $21M | ﹤0.01% |
825,422
-3,177
| -0.4% | -$78.5K |
|
|
APLS
1516
DELISTED
Apellis Pharmaceuticals
APLS
| $20.9M | ﹤0.01% |
405,039
-3,420
| -0.8% | -$181K |
|
1517
Pembina Pipeline
PBA
$28.7B
| $20.9M | ﹤0.01% |
616,395
+11,781
| +2% | +$395K |
|
1518
Upbound Group
UPBD
$1.14B
| $20.8M | ﹤0.01% |
924,462
+101,490
| +12% | +$2.17M |
|
1519
Northern Oil and Gas
NOG
$2.61B
| $20.8M | ﹤0.01% |
675,647
+226,998
| +51% | +$7.64M |
|
1520
LGI Homes
LGIH
$1.39B
| $20.7M | ﹤0.01% |
223,706
+12,245
| +6% | +$1.12M |
|
1521
Rush Enterprises Class A
RUSHA
$9.6B
| $20.6M | ﹤0.01% |
592,125
-67,097
| -10% | -$2.22M |
|
1522
Broadstone Net Lease
BNL
$4.38B
| $20.6M | ﹤0.01% |
1,272,537
+178,207
| +16% | +$2.98M |
|
1523
First Commonwealth Financial
FCF
$2.18B
| $20.6M | ﹤0.01% |
1,475,282
+250,044
| +20% | +$3.52M |
|
1524
Jack in the Box
JACK
$325M
| $20.6M | ﹤0.01% |
301,847
-24,703
| -8% | -$1.9M |
|
|
ITCI
1525
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $20.6M | ﹤0.01% |
388,766
+207
| +0.1% | +$10.4K |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.